OraNet is our international network of more than 400 investigative sites across the US, Europe, and Asia – each one carefully selected for its strict adherence to quality standards for ophthalmic clinical trial conduct.
Working with high-quality sites results in a clinical trial that is more likely to finish on time, on budget, with minimal data variability. Every OraNet site is composed of ophthalmologists and their staff who are experienced across all ophthalmology specialties including dry eye disease, allergic conjunctivitis, glaucoma, cataract, and diseases of the retina.
All OraNet sites are required to meet the following stringent qualifications:
Once selected, OraNet sites are extensively trained and supported by our in-house clinical trial specialists who work closely with each site to instruct investigators and staff before the start of each new protocol – as well as during the study to manage efficient trial execution and ensure protocol adherence. Access to Ora’s validated clinical models and scales standardizes study environments at OraNet sites, reduces variability among sites, and delivers more reliable clinical trial outcomes.
Ora selects sites based on the needs of your ophthalmology study. We will conduct feasibility and site selection based on your study design objectives and required patient population in order to match you with the best sites to help you meet your goals.
Gain exclusive access to retina patients at integrated practice-based research sites in the U.S. with Ora’s retina site and patient network designed to connect investigators, sponsors and patients. Exclusive access to an established network of retina patients means we enroll the right retina patient in the right trial at the right time for meaningful results.
Our retina network sites are located throughout the United States, integrated within thriving retina practices in cities with a high prevalence of people with age related macular degeneration and diabetic retina diseases. We’re invested in maintaining exclusive partnerships and close relationships with our network of sites and share a commitment to the highest standards of clinical research to deliver quality results.